Symbicort Study Finds Budesonide Component Key To Controlling Asthma
Executive Summary
A study of AstraZeneca's Symbicort (budesonide/ formoterol) as a reliever therapy for asthma exacerbations found that adding the inhaled corticosteroid budesonide results in additional reductions of severe exacerbations when compared to formoterol alone